MedTrace Logo

A Study to Examine the Safety and Toleration of PEP005 Topical Gel in Patients With Actinic Keratoses on the Top of the Hand

NCT00544297 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2015-04-02

No results posted yet for this study

Summary

The purpose of this study is to examine the safety and toleration of PEP005 Topical Gel, administered on an actinic keratosis (AK) treatment area on the top of a hand.

Conditions

  • Actinic Keratosis

Interventions

DRUG

PEP005 gel

Two day application, 0.05%

Sponsors & Collaborators

  • Omnicare Clinical Research

    collaborator INDUSTRY

  • Peplin

    lead INDUSTRY

Principal Investigators

  • Arthur P Bertolino, MD · Chief Medical Officer and VP Medical Affairs

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2008-01-31
Completion
2008-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00544297 on ClinicalTrials.gov